Asset

ABT-102

Abbott Laboratories Common Stock

Revenue

No revenue reported in loaded filings.

Clinical trials (1)

NCT IDPhaseStatusStartCompletionSponsor nameTitle
NCT00854659phase1completed2009-03-012009-06-01AbbottA Safety, Tolerability and Pharmacokinetic Study of ABT-102 in Healthy Subjects

FDA applications (0)

This company has no applications containing this asset.

Marketed products (0)